Mohindru Mani

Mohindru Mani is listed in filings as Chief Executive Officer at Cardiff Oncology, Inc.. This profile follows SEC Form 4 activity through Jun 22, 2026, including purchase activity. Recent filings connect the profile to Cardiff Oncology, Inc. (CRDF) and CytomX Therapeutics, Inc. (CTMX). The current snapshot covers public activity from Jul 1, 2024 to Jun 22, 2026. Reported amounts are shown as $29.9K to $69.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.